Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bacterial Infections and Mycoses

Free Subscription Articles published in Drugs Retrieve available abstracts of 22 articles: HTML format

Single Articles

March 2024
1. BLAIR HA
   SER-109 (VOWST()): A Review in the Prevention of Recurrent Clostridioides difficile Infection.
   Drugs. 2024;84:329-336.
   PubMed     Abstract available
   
   
   
2. SHIRLEY M
   Vonoprazan: A Review in Helicobacter pylori Infection.
   Drugs. 2024;84:319-327.
   PubMed     Abstract available
   
   
   September 2023
3. KEAM SJ
   Sulbactam/Durlobactam: First Approval.
   Drugs. 2023;83:1245-1252.
   PubMed     Abstract available
   
   
   July 2023
4. VENUTI F, Trunfio M, Martson AG, Lipani F, et al
   Extended and Continuous Infusion of Novel Protected beta-Lactam Antibiotics: A Narrative Review.
   Drugs. 2023;83:967-983.
   PubMed     Abstract available
   
   
   June 2023
5. SYED YY
   Rezafungin: First Approval.
   Drugs. 2023;83:833-840.
   PubMed     Abstract available
   
   
   May 2023
6. KANG C
   Keverprazan Hydrochloride: First Approval.
   Drugs. 2023;83:639-643.
   PubMed     Abstract available
   
   
   February 2023
7. GONZALES-LUNA AJ, Carlson TJ, Garey KW
   Emerging Options for the Prevention and Management of Clostridioides difficile Infection.
   Drugs. 2023;83:105-116.
   PubMed     Abstract available
   
   
   December 2022
8. EDWARDS BD, Field SK
   The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis.
   Drugs. 2022;82:1695-1715.
   PubMed     Abstract available
   
   
   October 2022
9. KHANNA S, Assi M, Lee C, Yoho D, et al
   Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
   Drugs. 2022;82:1527-1538.
   PubMed     Abstract available
   
   
   August 2022
10. NGAN NTT, Flower B, Day JN
    Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?
    Drugs. 2022;82:1237-1249.
    PubMed     Abstract available
    
    
    June 2022
11. SHIRLEY M
    20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.
    Drugs. 2022;82:989-999.
    PubMed     Abstract available
    
    
    
12. HOY SM
    Oteseconazole: First Approval.
    Drugs. 2022;82:1017-1023.
    PubMed     Abstract available
    
    
    March 2022
13. CHOU A, Welch E, Hunter A, Trautner BW, et al
    Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.
    Drugs. 2022;82:407-438.
    PubMed     Abstract available
    
    
    December 2021
14. REYNOLDS D, Kollef M
    The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.
    Drugs. 2021;81:2117-2131.
    PubMed     Abstract available
    
    
    October 2021
15. HOENIGL M, Sprute R, Egger M, Arastehfar A, et al
    The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.
    Drugs. 2021;81:1703-1729.
    PubMed     Abstract available
    
    
    September 2021
16. SYED YY
    Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections.
    Drugs. 2021;81:1559-1571.
    PubMed     Abstract available
    
    
    
17. HOY SM
    Contezolid: First Approval.
    Drugs. 2021;81:1587-1591.
    PubMed     Abstract available
    
    
    August 2021
18. LEE A
    Ibrexafungerp: First Approval.
    Drugs. 2021;81:1445-1450.
    PubMed     Abstract available
    
    
    
19. AARTS P, Dudink K, Vossen ARJV, van Straalen KR, et al
    Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.
    Drugs. 2021;81:1397-1410.
    PubMed     Abstract available
    
    
    July 2021
20. LIN EY, Adamson PC, Klausner JD
    Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.
    Drugs. 2021;81:1153-1169.
    PubMed     Abstract available
    
    
    February 2021
21. ZHANEL GG, Deng C, Zelenitsky S, Lawrence CK, et al
    Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
    Drugs. 2021;81:233-256.
    PubMed     Abstract available
    
    
    
22. HEO YA
    Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections.
    Drugs. 2021;81:377-388.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.